As the title says – I’m very tempted to start a position with HIMS seeing its recent and projected growth of around 80% along with strong balance sheet, very little debt, decent cash on hand etc..
My concerns are that institutions know something we don’t and they are selling even after the q2 triple beat the stock is 30% down. What is retail missing here?
My concerns are:
Bad reviews on some websites (difficult to know what to believe)
Questionable CEO credentials – only 34 with political views he has been plastering all over twitter.
No real moat – barriers to entry for mail order health diagnosis and delivery system low. Although Teladoc who is a direct competitor seem to be making a pigs ear if it, so HIMS have the capability to take their share more and more over the coming years.
TLDR; do the pros outweigh the cons with this company? Perhaps short term worth a gamble to go for a ‘double’ or so and reassess?
Leave a Reply